Dr. Charles Kunos is a Professor in the Department of Radiation Oncology in the University of Miami Sylvester Comprehensive Cancer Center (SCCC). He joined SCCC in 2023 and serves as the co-director of radiopharmaceutical development initiative for adult and pediatric cancer patients. He received his medical and doctorate degrees from Case Western Reserve University School of Medicine in Cleveland, Ohio. He undertook radiation oncology training at the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center at University Hospitals of Cleveland. He was formerly the NCI Gynecologic Oncology Group’s liaison for Radiation Medicine, serving on multiple committees and task forces as well as serving as a Phase I co-chair of the Developmental Therapeutics Committee between 2012 and 2015. His clinical research interests involve development of a diverse anticancer drug portfolio involving experimental therapeutic agents and radiopharmaceuticals that manipulate DNA damage responses by themselves or in combination with other treatments. He led NCI’s team that was granted Food & Drug Administration Orphan Drug Designation and Fast Track Designation for triapine in combination with cisplatin-radiation therapy for treatment of women with advanced stage uterine cervix cancer.

Rachel Miller is an assistant professor of gynecologic oncology at the University of Kentucky Markey Cancer Center. Dr. Miller received her MD from the University of Kentucky College of Medicine. She completed residency in obstetrics and gynecology and Dartmouth Hitchcock Medical Center in Lebanon, NH, followed by fellowship in gynecologic oncology at the University of Kentucky. Dr. Miller’s research interests include early detection of ovarian cancer, novel strategies in the treatment of ovarian cancer, chemotherapy-induced cognitive impairment, radical pelvic surgery, and robotic surgery for gynecologic cancers.

Denise Fabian, MD, is an Assistant Professor and the Associate Residency Program Director of Radiation Oncology at University of Kentucky. She attended college at Boston University, where she studied biochemistry and molecular biology along with international relations. Dr. Fabian returned to Ohio, where she earned her medical degree at the Ohio State University College of Medicine; she completed her residency training at Ohio State, as well. Her current work focuses on gynecologic malignancies, brachytherapy, and radiopharmaceuticals for neuro-oncology.